THE VALUE OF PMAPK AND PAKT IN HER2+BREAST CANCER WITH ANTHRACYCLINE-BASED NEOADJUVANT CHEMOTHERAPY

被引：0
|
作者：
Huang, L. [1 ,2 ]
Chen, T. [3 ]
Chen, C. [1 ,2 ]
Chen, S. [1 ,2 ]
Liu, Y. [1 ,2 ]
Wu, J. [1 ,2 ]
Shao, Z. [1 ,2 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China
[2] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China
[3] Shenzhen Sixth Peoples Hosp, Dept Thyroid & Breast Surg, Shenzhen, Peoples R China
来源：
BREAST | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [41] Are HER2 and TOP2A Useful As Prognostic or Predictive Biomarkers for Anthracycline-Based Adjuvant Chemotherapy for Breast Cancer?
    Pritchard, Kathleen I.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (24) : 3875 - 3876
  • [42] Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy
    Vargas-Roig, Laura M.
    Cuello-Carrion, F. Dario
    Fernandez-Escobar, Nicolas
    Daguerre, Pedro
    Leuzzi, Marcela
    Ibarra, Jorge
    Gago, Francisco E.
    Nadin, Silvina B.
    Ciocca, Daniel R.
    MOLECULAR ONCOLOGY, 2008, 2 (01) : 102 - 111
  • [43] Refining the indications for neoadjuvant chemotherapy for patients with HER2+breast cancer: A single institution experience
    Pomponio, Maria K.
    Burkbauer, Laura
    Goldbach, Macy
    Nazarian, Susanna M.
    Xie, Fei
    Clark, Amy S.
    Matro, Jennifer M.
    Fox, Kevin R.
    Shulman, Lawrence N.
    Keele, Luke J.
    Tchou, Julia
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (03) : 447 - 455
  • [44] Long-term outcomes after neoadjuvant trastuzumab and chemotherapy for HER2+breast cancer
    Gropper, A.
    Burstein, H. J.
    Harris, L.
    Anderson, K. S.
    Gold, J. M.
    Younger, W. J.
    Bunnell, C. A.
    Najita, J. S.
    Winer, E. P.
    Mayer, E. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Exercise training during anthracycline-based chemotherapy for breast cancer.
    Fraser, Steve
    Bigaran, Ashley
    Selig, Steve
    LaGerche, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR
    Daniele Generali
    Silvia Paola Corona
    Lajos Pusztai
    Roman Rouzier
    Giovanni Allevi
    Sergio Aguggini
    Manuela Milani
    Carla Strina
    Albane Frati
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 601 - 606
  • [47] Changes in protein expression in breast cancer after anthracycline-based chemotherapy
    Lee, Ho-chang
    Lee, JaeOk
    Park, In Ae
    KOREAN JOURNAL OF PATHOLOGY, 2007, 41 (03) : 165 - 170
  • [48] Economic analyses of toxicity secondary to anthracycline-based breast cancer chemotherapy
    Dranitsaris, G
    Tran, TM
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2174 - 2180
  • [49] Correlation between HER-2/neu amplification in fine needle aspirates from breast carcinoma and responses to neoadjuvant anthracycline-based chemotherapy
    Bozzetti, Cecilia
    Musolino, Antonino
    Personeni, Nicola
    Nizzoli, Rita
    Martella, Eugenia
    Lagrasta, Costanza
    Leonardi, Francesco
    Michiara, Maria
    Camisa, Roberta
    Ardizzoni, Andrea
    ANNALS OF ONCOLOGY, 2004, 15 : 16 - 16
  • [50] Concomitant radiotherapy, and anthracycline-based chemotherapy in adjuvant breast cancer treatment
    Ivaldi, G. B.
    Leonardi, M.
    Ferrari, A.
    Morra, A.
    Fossa, B. Jereczek
    Vavassori, A.
    Santoro, L.
    Orecchia, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S180 - S181
12345